Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Tops Revenue Estimates
1/3 00:05
Revolution Medicines, Inc. (RVMD) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.52 per share a year ago. These figures are adjusted for non-recurring items....